Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRK-750 for CIPN in Colorectal Cancer
NCT04282590Phase 2Withdrawn
- Sponsor
- Toray Industries
- Start
- Apr 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of TRK-750 in chemotherapy-induced peripheral neuropathy (CIPN), sponsored by Toray Industries. Planned start Apr 2020; status: withdrawn.
02
Drugs
TRK-750
03
Conditions
chemotherapy-induced peripheral neuropathy (CIPN)
Beyond the preview
Go deeper on NCT04282590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04282590.